These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6723647)
1. A specific disulfide bond associated with the activity of human urokinase. Its topological identification and reductive cleavage followed by kinetic changes in enzymatic reaction and affinity labeling. Miwa N; Sawada T; Suzuki A Eur J Biochem; 1984 May; 140(3):539-45. PubMed ID: 6723647 [TBL] [Abstract][Full Text] [Related]
2. Conformational changes in human urokinase induced by a specific reduction of disulfide bond in Cys-194-Cys-222 associated with exhibition of enzymatic activity. Miwa N; Sawada T; Suzuki A Biochim Biophys Acta; 1984 Nov; 791(1):1-8. PubMed ID: 6498202 [TBL] [Abstract][Full Text] [Related]
3. The effect of interaction between human urokinase and its competitive inhibitor, N alpha-benzoyl-L-arginine amide, on reduction of a specific SS bond related to enzymatic activity. Miwa N; Obata Y; Suzuki A Biochem Biophys Res Commun; 1983 Apr; 112(2):754-62. PubMed ID: 6342620 [TBL] [Abstract][Full Text] [Related]
4. A functionally active heavy chain derived from human high molecular weight urokinase. Sumi H; Robbins KC J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538 [TBL] [Abstract][Full Text] [Related]
5. Chymopapain A. Purification and investigation by covalent chromatography and characterization by two-protonic-state reactivity-probe kinetics, steady-state kinetics and resonance Raman spectroscopy of some dithioacyl derivatives. Baines BS; Brocklehurst K; Carey PR; Jarvis M; Salih E; Storer AC Biochem J; 1986 Jan; 233(1):119-29. PubMed ID: 3513753 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of high molecular weight urokinase and low molecular weight urokinase. Nobuhara M; Sakamaki M; Ohnishi H; Suzuki Y J Biochem; 1981 Jul; 90(1):225-32. PubMed ID: 7026550 [TBL] [Abstract][Full Text] [Related]
7. Effect of dithiothreitol on activity and protein structure of human urine urokinase. Kobayashi O; Matsui K; Minamiura N; Yamamoto T J Biochem; 1985 Jan; 97(1):37-44. PubMed ID: 3997796 [TBL] [Abstract][Full Text] [Related]
8. Reactions of L-ergothioneine and some other aminothiones with2,2'-and 4,4'-dipyridyl disulphides and of L-ergothioneine with iodoacetamide. 2-Mercaptoimidazoles, 2- and 4-thiopyridones, thiourea and thioacetamide as highly reactive neutral sulphur nucleophils. Carlsson J; Kierstan MP; Brocklehurst K Biochem J; 1974 Apr; 139(1):221-35. PubMed ID: 4463944 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor. Lijnen HR; De Cock F; Collen D Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373 [TBL] [Abstract][Full Text] [Related]
10. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism. Egelund R; Petersen TE; Andreasen PA Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406 [TBL] [Abstract][Full Text] [Related]
11. Reduction of disulfides in urokinase and insertion of a synthetic peptide. Homandberg GA; Wai T Biochim Biophys Acta; 1990 Apr; 1038(2):209-15. PubMed ID: 2331484 [TBL] [Abstract][Full Text] [Related]
12. Urokinase-catalysed plasminogen activation. Effects of ligands binding to the AH-site of plasminogen. Christensen U Biochim Biophys Acta; 1988 Nov; 957(2):258-65. PubMed ID: 3191143 [TBL] [Abstract][Full Text] [Related]
13. Structure of chymopapain M the late-eluted chymopapain deduced by comparative modelling techniques and active-centre characteristics determined by pH-dependent kinetics of catalysis and reactions with time-dependent inhibitors: the Cys-25/His-159 ion-pair is insufficient for catalytic competence in both chymopapain M and papain. Thomas MP; Topham CM; Kowlessur D; Mellor GW; Thomas EW; Whitford D; Brocklehurst K Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):805-20. PubMed ID: 8010964 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160. Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984 [TBL] [Abstract][Full Text] [Related]
15. Disulfide bond-modified trypsinogen. Role of disulfide 179-203 on the specificity characteristics of bovine trypsin toward synthetic substrates. Knights RJ; Light A J Biol Chem; 1976 Jan; 251(1):222-8. PubMed ID: 942666 [TBL] [Abstract][Full Text] [Related]
16. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin. Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788 [TBL] [Abstract][Full Text] [Related]
17. Kinetic studies on soluble and insoluble urokinases. Capet-Antonini FC; Tamenasse J Can J Biochem; 1975 Aug; 53(8):890-4. PubMed ID: 241473 [TBL] [Abstract][Full Text] [Related]
18. Details of the acyl-enzyme intermediate and the oxyanion hole in serine protease catalysis. Whiting AK; Peticolas WL Biochemistry; 1994 Jan; 33(2):552-61. PubMed ID: 8286385 [TBL] [Abstract][Full Text] [Related]
19. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
20. Identification of an active site histidine in urokinase. Ong EB; Johnson AJ; Schoellmann G Biochim Biophys Acta; 1976 Mar; 429(1):252-7. PubMed ID: 1260031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]